Vaccine iNews is a new segment dedicated to progress about about COVID-19 vaccines. and other vaccines. Currently there is a lot of controversy and issues surrounding COVID-19 vaccines and this new segment will not only address these but also provides updates about COVID-19 vaccines developments and progress. There are almost close to 168 COVID Vaccines being developed but 3 of the main covid-19 ...
Vaccine News: Media outlets are abuzz in the last 24 hours about a warning letter sent to the US FDA and Pfizer by a leading immunologist cum scientist in Pennslyvania, Dr Hooman Noorchashm.
The letter warns about the immunological danger of COVID-19 Vaccination in recently convalescent and asymptomatic carriers most especially to those who are elderly, frail or have significant car...
Vaccine News: A new study by researchers from University of East Anglia, Norwich-UK led by Professor Dr Alastair Grant and Professor Dr Paul R Hunter indicates that the current COVID-19 vaccines will not be able to attain herd immunity against the SARS-CoV-2 coronavirus.
While the COVID-19 pandemic continues to claim thousands of lives each day and cause severe disruptions to ordinary lif...
Vaccine News: A new research by scientists from Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID)-University of Cambridge, University College London, University of Kent and Addenbrookes Hospital-UK shows that the Pfizer-BioNTech vaccine exhibits reduced neutralization potential against SARS-CoV-2 B.1.1.7 variant.
The new study findings contradicts Pfizer&rsqu...
Vaccine News: As Moderna vaccines are being rolled out in California, the incidence of adverse reactions and individuals falling sick are raising alarms with many doctors who are in turn calling for an urgent halt of the vaccines and a proper investigation.
The state’s epidemiologist is urging a halt to more than 330,000 coronavirus vaccinations using a Moderna vaccine version becau...
Vaccine News: A new breaking development has emerged with a total of 23 deaths being reported by the Norwegian Medicines Agency in connection with the Pfizer’s /BioNTech vaccines. To date 13 of these cases have been assessed so far and confirmed as linked to the vaccines.
https://legemiddelverket.no/nyheter/meldte-bivirkninger-etter-koronavaksine-pr-14-januar-2021
Norway Reports 23 ...
Vaccine News: At least three Democratic members of the House of Representatives despite having been vaccinated with the Pzifer/BioNtech vaccine were tested positive after the violent intrusion of Capitol by Trump supporters who were instigated to do so by the President himself! The three house representatives despite being masked themselves had to shelter for hours in tight proximity with Republic...
Vaccine News: While the world is foolishly thinking that the COVID-19 vaccines are going to get things back to normal quickly, more concerning findings are emerging about the real efficacy of these vaccines that were basically initiated by the Trump administration (the same group that gave us scams like hydrocholoroquine, remdesivir, then Eli lily’s monoclonal antibodies and also Regeneron c...
Source: COVID-19 Vaccine News: Jan 06, 2021 22 days ago
COVID-19 Vaccine News: About 9 hours ago, the Norwegian Medicines Agency announced that two inmates in a nursing home died few days after receiving a COVID-19 vaccine made by the American pharmaceutical company Pfizer and its German partner BioNTech that is owned by a Turkish muslim national, Uğur Şahin.
https://legemiddelverket.no/nyheter/dodsfall-hos-sykehjemsbeboere-etter-koronavaksinerin...
Vaccine News: Individuals who have cosmetic facial fillers be it in their lips, nose, eye contours or elsewhere in their face will likely develop swellings and inflammation on those areas after having a dose of the Moderna’s vaccine.
This was observed during initial clinical trials and also in certain individuals as the vaccines rolled out
Also the U.S.FDA advisory committee ...
Vaccine News: An American health worker from Alaska had a serious allergic reaction after getting a Pfizer Inc and BioNTech’s COVID-19 vaccine shot and was hospitalized, but is now stable, U.S. public health authorities said on Wednesday.
The health worker with no known allergies suffered adverse reaction minutes after taking the Pfizer shot on Tuesday.
Similar cases were rep...
Vaccine News: A new preliminary study led by researchers from Oxford University and includes scientists from University College London, Université de Strasbourg-France and University of Birmingham-UK shows that a natural compound called spermidine, which helps immune cells self-clean, may improve vaccine protection in older adults.
According to the study abstract, older adults are ...
Vaccine Updates: America has just crossed the 300,000 COVID-19 deaths milestone a few minutes ago and more than 16.2 million Americans have been infected with the COVID-19 while in the United Kingdom, the situation is just as bad but we are unable to report any figures as most official figures are unreliable as a result as a result of a concerted effort by certain authorities to mask the real...
Vaccine News: It was officially announced by Peru health authorities on Friday that the government has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in one of its test volunteers.
It was reported that a participant had developed a neurological condition known as Guillain-Barre syndrome.
The Per...
Source: COVID-19 Vaccine News Dec 09, 2020 2 months ago
COVID-19 Vaccine News: The U.S. FDA has warned that four participants in Pfizer’s COVID-19 vaccine trials had developed facial paralysis while UK regulators have issued yet another warning that individuals with allergies should avoid the COVID-19 vaccine.
The U.S FDA commenting on the incident of the 4 individuals developing facial paralysis after having the Pfizer’s COVID-19 ...
Vaccine News: Scientists from the U.S. National Institute for Allergies and Infectious Diseases (NIAID) have reported that Moderna’s COVID-19 vaccine, mRNA-1273, caused the human immune system to produce potent antibodies that endures for at least three months.
The research findings were published in the peer reviewed New England Journal of Medicine. https://www.nejm.org/doi/full/10...
COVID-19 Scams: The purpose of the COVID-19 vaccines trials were to determine the safety of the vaccines, whether they elicited relevant and effective antibodies and T-cells and whether they offered protection to the recipients of the vaccines against the various SARS-CoV-2 strains in circulation. (Please also note that having antibodies and T cells elicited does not mean that one is protected as ...
COVID-19 Scams: Kinda sick of reading about so called ‘experts’ and leaders in various industries complaining that there is a lot of misinformation online and that people are lacking confidence to accept the new COVID-19 vaccines as result of that. However they themselves failed to reassure the public with proper facts and assume that the masses are really stupid. (Well maybe in certai...
Source: Thailand Medical News Nov 30, 2020 2 months ago
Despite appealing so many times and despite having a huge readership base, we had only 6 kind individuals who ever responded to our calls for help and support.
We desperately need funds to sustain this website and aso to continue with our various research especially for our herbal research for COVID-19 and our therapeutic teas for COVID-19. https://www.thailandmedical.news/news/new-therape...
COVID-19 Scams: While most of the moronic and non-credible media and ignorant individuals were celebrating AstraZeneca’s so called vaccine trial results including supposedly experts with huge vested business interest in the pharma industry like Dr Anthony Fauci, it has now come to light that there was a huge error in the manufacturing process of these vaccines which even AstraZeneca an...
COVID-19 Alerts: A new research that is among many that is emerging is indicating that natural deletions in the SARS-CoV-2 spike glycoprotein is driving antibody escape and many of the current vaccine candidates may end up being useless or worse even contribute to the phenomenon of ADE or antibody-dependent enhancement.
The new research by scientist from the University of Pittsburg and Ha...
Source: Antibody Resistant SARS-CoV-2 Nov 22, 2020 2 months ago
Antibody Resistant SARS-CoV-2: A new study and modeling platform created by researchers and scientist from Harvard Medical School, Dana-Farber Cancer Institute, Boston Children’s Hospital, University of Washington, Fractal Therapeutics,-Cambridge, Massachusetts Institute of Technology, Microsoft Research, Mark S. Hixon Consulting and Boston University alarmingly indicates that due to t...
Vaccine News: New alarming study findings based on a research by scientist from the University of Oxford-UK has now put numerous vaccines that are under development and soon to be used on masses under a new spotlight.
The study team has revealed that site-specific glycosylation differs between spike proteins derived from SARS-CoV-2 and a viral vector-based vaccine candidate. A significant...
COVID-19 Scams: While the majority of the stupid people are still placing their hopes in COVID-19 vaccines with more ‘bribed’ Western journalists and media still extolling merits on these vaccines, various pharmaceutical and biotech executives from companies like Pfizer, Moderna, Novavax are quickly cashing out on their shares while the going is good.
We even have some media i...
Source: Coronavirus News Nov 15, 2020 2 months ago
Coronavirus News: Even if any of the current COVID-19 vaccines under development is able to offer only short-term protection against certain strains of the SARS-CoV-2 coronavirus without causing any long term adverse effects such as ADE (Antibody-dependent enhancement) or other issues, the vaccines will need to be constantly reformulated as emerging studies show that the coronaviruses are constant...
Vaccine News: Another latest development in the trillion dollar COVID-19 vaccine sector that is plagued with scams, lies, cover-ups and greed as Brazil announces a sudden suspension of all clinical trials involving the Chinese COVID-19 vaccine called Coronavac made by Sinovac Biotech.
24 hours ago, Brazil's health regulator said it had suspended clinical trials of a Chinese-developed ...
Source: COVID-19 Vaccine Nov 10, 2020 3 months ago
COVID-19 Vaccine: American headquartered pharmaceutical giant Pfizer spend a fortune on a PR conference and paying off numerous unethical media writers and media to do an elaborate piece about its vaccine which it claims is more than 90 percent effective. In the last few hours its stocks were rallying and God knows who is going to make millions but the key issue is that there were no published stu...
Vaccine News: As an individual that has been observing with skepticism the vaccines and therapeutic programs initiated in America under the corrupted and incompetent Trump administration and Dr Anthony Fauci with so many other scammers in play including a group of clandestine businessmen and billionaires headed by Tom Cahill and Nick Ayers, an aide of Mike Spence, it shocking to see that the trill...
COVID-19 Scams: Associate Editor at the British Medical Journal (BMJ) Professor Dr Peter Doshi, in a daring but truthful revelation yesterday warned that vaccine trials currently underway are not designed to tell us if they will save lives.
https://www.bmj.com/content/371/bmj.m4037
Although several COVID-19 vaccine trials are now in their most advanced phase 3 stage, but what will i...
Vaccine News: Brazil's health authority Anvisa reported that Brazilian volunteer participating in clinical trials of the COVID-19 vaccine developed by Oxford University and AstraZeneca has died on the 18th of October.
It was unclear whether the volunteer had received the vaccine or a placebo and in countries like Brazil, the organizers can easily switch the facts in or...
Source: Vaccine-COVID-19 Oct 16, 2020 3 months ago
Vaccine-COVID-19: As more studies are showing that antibodies will ultimately only provide short term optimal protection of anything between 10 to 16 weeks and while at the same time other studies are also showing that many AAV (Adeno Associated Virus) vector RNA vaccines that are currently being developed and are in phase 3 trials might actually cause certain adverse effects https://www.thailandm...
Vaccine News: Pharmaceutical giant Johnson & Johnson announced on late Monday that it had temporarily halted its COVID-19 vaccine trial because one of its participants had become seriously sick.
A spokesman for Johnson and Johnson told Thailand Medical News, "We have halted further dosing in all our COVID-19 vaccine candidate clinical trials globally due to a particpant...
COVID-19 Help: While tens of thousands are getting infected daily and thousands are dying each day, millions elsewhere are worried and are trying to find ways to help themselves and their loved ones and the only thing that stupid health authorities and incompetent corrupted governments around the world are doing are giving false hopes by an anticipated COVID-19 vaccine that many think will solve t...
Source: COVID-19 Vaccines Oct 08, 2020 4 months ago
COVID-19 Vaccines: A group of American researchers from the Swedish Medical Center-Seattle, University of Washington-Seattle, Stanford University-California, LabCorp-Seattle and the Vaccine and Infectious Disease Division, Fred Hutch-Seattle after reviewing a case of a patient who got re-infected with a different strain of the SARS-CoV-2 coronavirus ie the more potent and infectious D614G mu...
Vaccine News: Researchers from Harvard’s Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS) along with support from Perelman School of Medicine, University of Pennsylvania, have developed a platform technology that uses red blood cells to deliver antigens to antigen-presenting cells (APCs) in the spleen, generating ...
Medical Law: According to a new research paper in the journal Science co-written by a University of Illinois, Urbana-Champaign legal expert who studies the policy implications of advanced biotechnologies. well-intentioned “citizen scientists” developing homemade COVID-19 vaccines may believe they are inoculating themselves against the ongoing pandemic, but the pract...
Source: Vaccines-COVID-19 Oct 01, 2020 4 months ago
Vaccines-COVID-19: The NIAID And Moderna Inc Phase 1 clinical trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.
The trial results were published in the New England Journal of Medicine. https://www.nejm.org/doi/10.1056/NEJMoa2028436
The new experimental v...
Source: COVID-19 Vaccine Exclusive Sep 29, 2020 4 months ago
COVID-19 Vaccine Exclusive: Adeno-associated viral vectors to deliver gene therapies and vaccines are a growing platform that is being used by more and more pharmaceutical companies in drug and vaccine development. But unknown to many there are possible repercussions taking such AAV vectors based meds or vaccines.
Two gene therapies using adeno-associated virus (AAV) vectors to deliver ge...
Source: COVID-19 Vaccine Sep 14, 2020 5 months ago
COVID-19 Vaccine : The AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today (Monday,14th September) sharply criticized pharmaceutical and biotech companies working on COVID-19 vaccines over a near total lack of transparency on the companies’ respective trials, including setbacks with AstraZeneca’s vaccine trial that briefly forced its suspensio...
Source: Vaccines-COVID-19 Sep 14, 2020 5 months ago
Vaccines-COVID-19: Indian researchers from vaccine developer Bharat Biotech International Ltd in collaboration with researchers National Institute of Virology-Indian Council of Medical Research have conducted a preclinical study demonstrating the safety and efficacy of a new candidate vaccine against the SARS-CoV-2 coronavirus, the pathogen that causes the COVID-19 disease.
The ...
Source: Vaccines-COVID-19 Sep 13, 2020 5 months ago
Vaccines-COVID-19: The world’s oral recombinant adenoviral mucosal COVID-19 vaccine by Vaxart, Inc, a California based biotechnology company that is administered by tablet rather than by injection, has demonstrated positive results in a inducing potent systemic and mucosal immune responses in preclinical studies.
The study findings were published on a preprint server and are current...
Source: COVID-19 Immunity Sep 09, 2020 5 months ago
COVID-19 Immunity is short-lived for those who had mild symptoms when they were first infected with the SARS-CoV-2 coronavirus or were asymptomatic according to a new study by Chinese researchers from the Army Medical University in Chongqing led by Dr Ye Lilin, a leading Immunologist from the University’s Institute of Immunology.
The study also indicates that the absence of the key ...
Vaccine-COVID-19: It was announced the last few hours that the large phase 3 clinical trial of the COVID-19 vaccine AZD1222 developed by the University of Oxford and Astrazenaca was stopped in the last 24 hours and put on hold as a result of reported serious adverse reactions.
The sudden stoppage affected numerous testing sites globally especially in the United States and United Kingdom a...
Source: COVID-19 Next Generation Vaccines Sep 07, 2020 5 months ago
COVID-19 Next Generation Vaccines: Cambridge based Elicio Therapeutics has developed a next generation COVID-19 vaccine ELI-005 that is expected to start initial clinical trials soon. Unlike most of the current genetic based vaccines under development or in phase 3 trials, this lymph node-targeting vaccine is composed of an adjuvant developed using the company’s Amphiphile technology and the...
Source: COVID-19 Vaccine Sep 02, 2020 5 months ago
COVID-19 Vaccine researchers from UK and Taiwan have demonstrated the potential of a new candidate vaccine called RBD-SpyVLP against the SARS-CoV-2 coronavirus in animal models.
In vivo trials involving animal models such as mice and pigs, low doses of the vaccine triggered a potent neutralizing antibody response that was stronger than the response induced by serum taken from patients who...
Source: COVID-19 Vaccine Aug 31, 2020 5 months ago
COVID-19 Vaccine: New studies are showing that T cell immunity is necessary to provide robust and durable protection against reinfection with the SARS-CoV-2 coronavirus. This implies that the epitopes specific to the SARS-CoV-2 coronavirus which are capable of eliciting this type of response across a huge number of individuals need to be identified.
An epitope, also known as ant...
Source: COVID-19 Vaccine Aug 31, 2020 5 months ago
COVID-19 Vaccine: The chief of the US Food and Drug Administration, Dr Stephen Hahn raised the possibility that a vaccine against the SARS-CoV-2 coronavirus might be given emergency approval even before the end of trials designed to ensure its safety and effectiveness.
However such a request for extraordinary approval would have to come from the vaccine developer, Dr Stephen Hah...
Source: COVID-19 Vaccine Aug 24, 2020 5 months ago
COVID-19 Vaccine: A media release by Agence France-Presse(AFP) reports that a senior Catholic archbishop has warned he is "deeply troubled" by Australia's vaccine deal with AstraZeneca, saying the potential vaccine uses a fetal cell line that creates an "ethical quandary" for Christians.
This is the first time that Thailand Medical News is aware that fetal cell lin...
Source: COVID-19 Vaccine Aug 22, 2020 5 months ago
COVID-19 Vaccine: Researchers from Washington University School of Medicine-St. Louis have developed a vaccine that targets the SARS-CoV-2 coronavirus and can be administered through the nose in one dose.
Studies in mice models susceptible to the SARS-CoV-2 coronavirus have proven to be effective in preventing infection.
The study team next plans to test the vaccine in nonhuman pri...
Source: COVID-19 Vaccines Aug 21, 2020 5 months ago
COVID-19 Vaccines: Pfizer Inc. and BioNTech has released additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation.
The clinical data is published on a preprint server and is pending peer-review. https://www.medrxiv.org/content/10.1101/2020.08...
Source: COVID-19 Vaccine Aug 13, 2020 6 months ago
COVID-19 Vaccine: A new vaccine made from a mild virus genetically modified to carry a key gene from the SARS-CoV-2 coronavirus is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to research findings from Washington University School of Medicine in St. Louis.
Co-senior author Dr Michael S. Diamond, MD, PhD, the Herbert S. Gasser Profess...
Source: COVID-19 Vaccine Aug 10, 2020 6 months ago
COVID-19 Vaccine: Results of the phase one trial of NovaVAx’s NVX-CoV2373 recombinant nanoparticle vaccine that is manufactured at Emergent Biosolutions, was found to be well tolerated and immunogenic including inducing T-cell response and neutralization antibodies four-fold higher than the mean observed in hospitalized COVID-19 patients.
Though several promising candidates are already on...
Source: COVID-19 Vaccine Aug 09, 2020 6 months ago
COVID-19 Vaccine: Biotech and medical researchers from the University of Chicago and Duke University have created a new vaccine technology platform that allows the generation of the more effective vaccines with the fewest side effects using self-assembling peptide nanofibers tagged with antigens to prime the immune system against a potential invasion.
The research findings were published ...
Source: COVID-19 Vaccines Aug 07, 2020 6 months ago
COVID-19 Vaccines: As the world eagerly anticipates the arrival of a truly effective COVID-19 vaccine, it is emerging that one country is most likely to least benefit from it despite spending the most money compared to any other country in the world to secure a sufficient supply of the vaccine for its population.
In the United States where more than 42 percent of its population is obese, ...
Source: COVID-19 Vaccine Aug 06, 2020 6 months ago
COVID-19 Vaccine: Maryland-based Novavax is yet another biopharma company reporting promising early-stage data for a potential COVID-19 vaccine.
The biopharma company announced data from Phase I of its Phase I/II placebo-controlled trial of its vaccine with and without Matrix-M adjuvant. The trial was conducted in healthy adults 18 to 59 years of age.
The vaccin...
Source: COVID-19 Vaccine Aug 04, 2020 6 months ago
COVID-19 Vaccine: Russia’s Minister for Health Mikhail Murashko announced that Russia is planning a nationwide program to vaccinate its population against COVID-19 starting in October. The vaccine has not yet completed clinical trials. Murashko indicated they would begin by vaccinating teachers and health care workers.
He also told the RIA state news agency that while in t...
.jpg)
